ZIMMER BIOMET HOLDINGS INC
ZBHNYSETrading Snapshot
- Day Range
- β
- 52-Week Range
- $79.12 β $104.15
- Volume (shares)
- β
- Avg Volume (shares)
- β
- Shares Outstanding
- 190.7M
- Next Earnings
- β
Fundamentals Snapshot
- Annual Revenue
- $8.23B
- Last Q Revenue
- $2.18B
- P/E Ratio
- 22.8
- P/S Ratio
- 2.2x
- EPS (TTM)
- $4.11
- Dividend Yield
- 1.02%
- Dilution (1yr)
- β0.9%
ZIMMER BIOMET HOLDINGS INC
ZBHAbout ZIMMER BIOMET HOLDINGS INC
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Latest News & Updates
News unavailable.